These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7051051)

  • 21. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
    Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
    J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
    Aiken JW; Shebuski RJ; Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced release of a 'prostacyclin-like' substance from aortic strips of spontaneously hypertensive rats.
    Botha JH; Leary WP; Asmal AC
    Prostaglandins; 1980 Feb; 19(2):285-9. PubMed ID: 6992226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac prostacyclin release: stimulation by hypoxia and various agents.
    Kirstein A
    Scand J Haematol Suppl; 1979; 34():105-11. PubMed ID: 384504
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential inhibition of prostacyclin production and platelet aggregation by aspirin.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Lancet; 1979 Dec; 2(8154):1213-7. PubMed ID: 92623
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreased vascular prostacyclin in juvenile-onset diabetes.
    Silberbauer K; Schernthaner G; Sinzinger H; Piza-Katzer H; Winter M
    N Engl J Med; 1979 Feb; 300(7):366-7. PubMed ID: 366410
    [No Abstract]   [Full Text] [Related]  

  • 27. Rat's vessel wall generates an antiaggregatory substance independent of prostacyclin production.
    Schattner MA; Gimeno M; Lazzari MA
    Prostaglandins Leukot Med; 1985 Sep; 19(3):251-60. PubMed ID: 3864169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The road to prostacyclin.
    Vane JR
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():11-9. PubMed ID: 2936071
    [No Abstract]   [Full Text] [Related]  

  • 29. Hydrocortisone inhibits platelet prostaglandin and endothelial prostacyclin production.
    Jørgensen KA; Stoffersen E
    Pharmacol Res Commun; 1981 Jun; 13(6):579-86. PubMed ID: 6794043
    [No Abstract]   [Full Text] [Related]  

  • 30. Stimulation of prostacyclin release from vessel wall by Bay g 6575, an antithrombotic compound.
    Vermylen J; Chamone DA; Verstraete M
    Lancet; 1979 Mar; 1(8115):518-20. PubMed ID: 85106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Almitrine increases plasma fibrinolytic activity through the release of prostacyclin from lungs into circulation.
    Korbut R; Byrska-Danek A; Gryglewski RJ
    Pharmacol Res Commun; 1982 Nov; 14(10):959-65. PubMed ID: 6760210
    [No Abstract]   [Full Text] [Related]  

  • 32. Release of prostaglandins E2, I2, and D2 from perfused rabbit vascular tissue stimulated by ricinoleic acid.
    Juan H
    Prostaglandins Med; 1981 Sep; 7(3):209-15. PubMed ID: 7029584
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiotensin II-induced renal prostacyclin release suppresses platelet aggregation in the anesthetized dog.
    Shebuski RJ; Aiken JW
    Adv Prostaglandin Thromboxane Res; 1980; 7():1149-52. PubMed ID: 6989184
    [No Abstract]   [Full Text] [Related]  

  • 34. Pentoxifylline enhances formation of prostacyclin from rat vascular and renal tissue.
    Sinzinger H
    Prostaglandins Leukot Med; 1983 Oct; 12(2):217-26. PubMed ID: 6359176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-keto PGE1: a possible metabolite of prostacyclin having platelet antiaggregatory effects.
    Quilley CP; McGiff JC; Lee WH; Sun FF; Wong PY
    Hypertension; 1980; 2(4):524-8. PubMed ID: 6995292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of isosorbide dinitrate and isosorbide-5-mononitrate on prostacyclin (PGI2) and thromboxane A2 (TXA2) generation in rat and human arteries.
    Nakabayashi S; Uyama O; Nagatsuka K; Uehara A; Wanaka A; Yoneda S; Kimura K; Kamata T
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):323-32. PubMed ID: 3887528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity.
    Kelton JG; Hirsh J; Carter CJ; Buchanan MR
    J Clin Invest; 1978 Oct; 62(4):892-5. PubMed ID: 359598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin-related renin release from rabbit renal cortical slices.
    Spokas EG; Wong PY; McGiff JC
    Hypertension; 1982; 4(3 Pt 2):96-100. PubMed ID: 7040243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.